Summit Therapeutics (SMMT)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from SMMT's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Summit Therapeutics's 10-K filings. The deep dive has 15+ years, quarters and every line.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2M | $705,000 | $0 | $0 | — |
| Net income | -$89M | -$79M | -$615M | -$221M | -$1.1B |
| Free cash flow | -$73M | -$42M | -$77M | -$142M | -$324M |
| EPS (diluted) | -$0.67 | -$0.41 | -$0.99 | -$0.31 | -$1.44 |
| Operating margin | -4764.3% | -10225.4% | — | — | — |
Where the revenue comes from
Revenue by products, fiscal 2019.
Superinvestors who own SMMT
From each investor's latest 13F filing (what a 13F shows). 2 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
Added | $8M | 0.00% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Held | $229,142 | 0.00% | Q2 2026 |
Insider buying
Open-market purchases by Summit Therapeutics's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Oct 21, 2025 | Mahkam Zanganeh |
26,680 | $18.74 | $499,983 |
| Oct 21, 2025 | Robert W Duggan |
26,680 | $18.74 | $499,983 |
| Oct 21, 2025 | Yu Xia |
533,617 | $18.74 | $10M |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when SMMT trades at or below it.
Free accounts get 3 price alerts. No card needed.
In the full deep dive
Questions
Are Summit Therapeutics insiders buying the stock?
3 open-market insider purchases of SMMT in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Summit Therapeutics?
2 of the superinvestors Investingly tracks hold SMMT in their latest 13F, including Cliff Asness, Joel Greenblatt.
Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.